Buprenorphine Extended-Release Injection and Inotersen Subcutaneous
Determining the interaction of Buprenorphine Extended-Release Injection and Inotersen Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Inotuzumab ozogamicin
- Buprenorphine Extended-Release Injection-Inotuzumab ozogamicin Intravenous
- Buprenorphine Extended-Release Injection-Inova
- Buprenorphine Extended-Release Injection-Inova 4/1 topical
- Buprenorphine Extended-Release Injection-Inova 8/2 topical
- Buprenorphine Extended-Release Injection-Inova ACT
- Inotersen Subcutaneous-Buprenorphine implant
- Inotersen Subcutaneous-Buprenorphine Injection
- Inotersen Subcutaneous-Buprenorphine injection - Buprenex
- Inotersen Subcutaneous-Buprenorphine injection - Sublocade
- Inotersen Subcutaneous-Buprenorphine Intradermal
- Inotersen Subcutaneous-Buprenorphine oral/buccal